Article Abstract

Recent evidence on delamanid use for rifampicin-resistant tuberculosis

Authors: Emanuele Pontali, Rosella Centis, Lia D’Ambrosio, Federica Toscanini, Giovanni Battista Migliori

Abstract

Delamanid is one of the two most recently approved new anti-tuberculosis (TB) drugs.

Article Options

Download Citation